Exhibit 10.1

 

NOTE AND WARRANT PURCHASE AGREEMENT

 

This NOTE AND WARRANT PURCHASE AGREEMENT, dated as of August 13, 2012 (this
“Agreement”), is entered into by and among BLUEFLY, INC., a Delaware corporation
(the “Company”), PRENTICE CONSUMER PARTNERS, LP, a Delaware limited partnership
(“Prentice”), and RHO VENTURES VI, L.P., a Delaware limited partnership (“Rho”).
Each of Prentice and Rho are from time to time referred to herein as an
“Investor” and, collectively, the “Investors.”

 

RECITALS

 

WHEREAS, Prentice desires to purchase from the Company, and the Company desires
to issue and sell to Prentice, (i) secured subordinated promissory notes in an
aggregate principal amount of One Million Five Hundred Thousand Dollars
($1,500,000), in the form attached hereto as Exhibit A (the “Prentice Notes”),
together with (ii) a related warrant to acquire shares of the Company’s common
stock, par value $0.01 per share (the “Common Stock”), in the form attached
hereto as Exhibit C (the “Prentice Warrant”), in each case, on the terms, and
subject to the conditions, contained herein.

 

WHEREAS, Rho desires to purchase from the Company, and the Company desires to
issue and sell to Rho, (i) secured convertible subordinated promissory notes in
an aggregate principal amount of One Million Five Hundred Thousand Dollars
($1,500,000), in the form attached hereto as Exhibit B (the “Rho Notes,” and,
together with the Prentice Notes, the “Notes”), together with (ii) a related
warrant to acquire shares of Common Stock, in the form attached hereto as
Exhibit C (the “Rho Warrant,” and, together with the Prentice Warrant, the
“Warrants”), in each case, on the terms, and subject to the conditions,
contained herein.

 

As used in this Agreement, the following terms shall have the following
meanings: (i) the term “Initial Securities” shall mean, collectively, the Notes
and the Warrants, (ii) the term “Note Conversion Securities” shall mean the
shares of Common Stock or Subsequent Round Securities (as defined in the Rho
Notes) issuable upon conversion of the Rho Notes, (iii) the term “Warrant
Conversion Securities” shall mean the shares of Common Stock issuable upon
exercise of the Warrants, and (iv) the term “Securities” shall mean,
collectively, the Initial Securities, the Note Conversion Securities and the
Warrant Conversion Securities.

 

AGREEMENT

 

NOW, THEREFORE, in consideration for the mutual covenants contained herein, and
for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto, intending to be legally bound,
agree as follows:

 

ARTICLE I
PURCHASE AND SALE OF INITIAL SECURITIES; STOCKHOLDER APPROVAL

 

SECTION 1.1 Initial Securities. Subject to the terms and conditions hereof, the
Company hereby (a) issues and sells to Prentice, and Prentice hereby purchases
from the Company, the

 

 

 

 

Prentice Notes and (b) issues and sells to Rho, and Rho hereby purchases from
the Company, the Rho Notes. In consideration for the purchase by the Investors
of the Notes, the Company also hereby (x) issues and sells to Prentice, and
Prentice hereby purchases from the Company, the Prentice Warrants and (y) issues
and sells to Rho, and Rho hereby purchases from the Company, the Rho Warrants.
The purchase and sale of the Initial Securities is sometimes referred to herein
as the “Closing.”

 

SECTION 1.2 Purchase Price. The aggregate purchase price for the Initial
Securities to be purchased by each Investor is the amount set forth opposite
such Investor’s name in Schedule 1 (the “Purchase Price”).

 

SECTION 1.3 Stockholder Approval.

 

(a)          The Company shall take such actions as are reasonably necessary to
obtain the Stockholder Approval (as defined below) with respect to the
conversion of the Rho Notes and the exercise of the Rho Warrant and the Prentice
Warrant through an action by majority written consent of the stockholders, to be
signed and delivered by each of the Investors at or prior to Closing (the
“Stockholder Written Consent”). The Company shall prepare and file with the
United States Securities and Exchange Commission (the “Commission”) within 45
days after the Closing, an information statement relating to the Stockholder
Written Consent (the “Information Statement”). The Company shall use its
reasonable best efforts to respond to any comments of the Commission and to
obtain effectiveness of the Information Statement as promptly as reasonably
practicable. The Company shall mail the Information Statement to each of the
Company’s stockholders as promptly as reasonably practicable after responding to
all such comments received by the Commission to the satisfaction of the
Commission.

 

(b)          The Company will notify the Investors promptly of the receipt of
any comments from the Commission for amendments or supplements to the
Information Statement, and will supply the Investors with copies of all
correspondence between the Company or any of its representatives, on the one
hand, and the Commission, on the other hand, with respect to the Information
Statement. If there shall occur any event that should be set forth in an
amendment or supplement to the Information Statement, the Company will promptly
prepare and mail to its stockholders such amendment or supplement. The Company
will not mail any Information Statement, or any amendment or supplement thereto,
to which any Investor reasonably objects after being afforded the opportunity to
review the same. The Investors shall cooperate with the Company in the
preparation of the Information Statement or in responding to any comments of the
Commission, and the Investors shall promptly notify the Company if any
information supplied by it for inclusion in the Information Statement shall have
become false or misleading, and shall cooperate with the Company in
disseminating the Information Statement, as so amended or supplemented, to
correct any such false or misleading information.

 

(c)          Each Investor hereby agrees to vote or cause to be voted all shares
of the Company’s voting stock that are beneficially owned by such Investor, or
over which such Investor has or shares voting control, and to cause every
Affiliate (as such term is defined in Rule 12b-2 of the Exchange Act) of the
Investor to vote or cause to be voted, from time to time and at all times, in
whatever manner as shall be necessary to ensure that the Stockholder Approval is
obtained,

 

2

 

 

including without limitation, by delivering to the Company a Stockholder Written
Consent that is duly executed by such Investor and each of its Affiliates (as
applicable) within 10 days of the Closing. “Stockholder Approval” means such
approval of the stockholders of the Company as may be necessary under the rules
of the NASDAQ Capital Market or any other national securities exchange or
quotation system upon which the Common Stock may be listed from time to time, in
order to permit (i) the exercise in full of the conversion rights set forth in
Section 5 of the Rho Notes (without giving effect to any limitation in such
Section 5 relating to any such rules) and (ii) the exercise in full of the
rights set forth in the Warrants.

 

SECTION 1.4 Use of Proceeds. The Company shall use the proceeds from the
issuance of the Initial Securities solely for working capital and general
corporate purposes.

 

SECTION 1.5 Registration Rights. Rho shall be entitled to registration rights in
respect of the Note Conversion Securities and the Warrant Conversion Securities
issuable upon exercise of the Rho Warrant, and, to the extent Rho exercises its
rights under this Section 1.5 by providing a Notice (as defined below), Prentice
shall be entitled to simultaneous “piggy-back” shelf registration rights in
respect of the Warrant Conversion Securities issuable upon exercise of the
Prentice Warrant, in each case, consistent with the registration rights granted
pursuant to the Amended and Restated Registration Rights Agreement, dated as of
September 7, 2011 (the “2011 Agreement”), by and among the Company and the other
parties thereto, applied mutatis mutandis, including, without limitation, the
Company’s obligation to use its commercially reasonable efforts to effect the
registration contemplated by Section 2.2.1 of the 2011 Agreement; provided,
however, that (i) the Filing Deadline (as defined in the 2011 Agreement) with
respect to the Company’s obligation to prepare and file a shelf registration
statement covering such securities shall be a date 60 days following the date of
the Company’s receipt of written notice (the “Notice”) from Rho requesting the
registration of such securities (or 90 days following the date of the Company’s
receipt of the Notice if the Company determines that such longer period is
reasonably necessary to avoid filing a shelf registration statement including or
incorporating by reference financial statements that do not comply with the
requirements of Rule 3-12 of Regulation S-X, as amended, or any successor rule)
and (ii) the 180-day Required Effectiveness Deadline (as defined in the 2011
Agreement) shall also commence on the first day following the Company’s receipt
of the Notice; and provided, further, however, that, notwithstanding anything to
the contrary contained herein or in the 2011 Agreement, the provisions of
Section 2.2.4 and Section 2.2.5 of the 2011 Agreement shall be inapplicable to
the registration of the shares of Common Stock or Subsequent Round Securities
issuable upon conversion of Notes contemplated by this Section 1.5.

 

ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

The Company hereby represents and warrants as of the date hereof (except for the
representations and warranties that speak as of a specific date, which shall be
made as of such date), to the Investors that the following representations and
warranties are true and complete, except as set forth in the Schedules delivered
herewith. The Schedules shall be arranged in sections corresponding to the
numbered sections contained in this Article II, and the disclosures in any
section of the schedules shall qualify other sections in this Article II to the
extent it is reasonably apparent from a reading of the disclosure that such
disclosure is applicable to such other

 

3

 

 

sections. Statements qualified by the “Company’s knowledge” or phrases of
similar import means that such statement is based upon the knowledge of the
executive officers of the Company having responsibility for the matter or
matters that are the subject of the statements.

 

SECTION 2.1 Subsidiaries. The Company has no direct or indirect subsidiaries,
other than (i) Eyefly, LLC, a Delaware limited liability company in which it has
a 52% membership interest and (ii) EVT Acquisition Co., LLC, a wholly-owned
Delaware limited liability company (collectively, the “Subsidiaries”).

 

SECTION 2.2 Organization and Qualification. The Company and each of its
Subsidiaries is an entity duly incorporated or organized (as applicable),
validly existing and in good standing under the laws of the State of Delaware,
with the requisite entity power and authority to own or lease and use its
properties and assets and to carry on its business as currently conducted.
Neither the Company nor any of its Subsidiaries is in violation of any of the
provisions of its certificate of incorporation or certificate of formation or,
in any material respects, its by-laws, operating agreement or other
organizational or charter documents. Each of the Company and its Subsidiaries is
duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the
business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may
be, would not reasonably be expected to have (i) a material and adverse effect
on the legality, validity or enforceability of this Agreement, the Notes or the
Warrants (collectively, the “Transaction Documents”), (ii) a material and
adverse effect on the results of operations, assets, business, condition
(financial or otherwise) or liabilities (including contingent liabilities) of
the Company or the Company and its Subsidiaries, taken as a whole, or (iii) any
adverse impairment to the Company’s ability to perform in any material respect
on a timely basis its obligations under the Transaction Documents (each of the
items listed in clauses (i)-(iii), a “Material Adverse Effect”).

 

SECTION 2.3 Authorization; Enforcement; Validity. The Company has the requisite
corporate power and authority to enter into and to consummate the transactions
contemplated by each of the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The Company’s execution and delivery of
each of the Transaction Documents and the consummation by it of the transactions
contemplated hereby and thereby (including, but not limited to, (i) the sale and
delivery of the Initial Securities, (ii) the issuance of the Note Conversion
Securities in accordance with the terms of the Rho Notes and (iii) the issuance
of the Warrant Conversion Securities in accordance with the terms of the
Warrants) have been duly authorized by all necessary corporate action on the
part of the Company, and no further corporate action is required by the Company,
its board of directors or its stockholders in connection therewith other than in
connection with (x) the Stockholder Approval and (y) any amendment to the
Company’s certificate of incorporation (as amended or restated from time to
time) as may be necessary to increase the number of shares of Common Stock
authorized thereunder so as to enable the Company to issue Note Conversion
Securities in connection with any Subsequent Round of Financing (as defined in
the Rho Notes) and the approval by the Company’s stockholders of any such
amendment (a “Charter Amendment”). Each of the Transaction Documents has been
(or upon delivery will have been) duly executed by the Company and is, or when
delivered in accordance with the terms hereof, will constitute the legal, valid
and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as such enforceability

 

4

 

 

may be limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement
of, creditors’ rights and remedies or by other equitable principles of general
application, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as
indemnification and contribution provisions may be limited by applicable law.

 

SECTION 2.4 No Conflicts. The execution, delivery and performance by the Company
of the Transaction Documents and the consummation by the Company of the
transactions contemplated hereby or thereby (including, without limitation, (A)
the sale and delivery of the Initial Securities, (B) the issuance of the Note
Conversion Securities in accordance with the terms of the Rho Notes and (C) the
issuance of the Warrant Conversion Securities in accordance with the terms of
the Warrants) do not and will not (i) conflict with or violate any provisions of
the Company’s certificate of incorporation, by-laws or otherwise result in a
violation of the organizational documents of the Company, (ii) conflict with,
result in any breach of any provision of, or constitute a default (or an event
that with notice or lapse of time or both would result in a default) under,
result in the creation of any lien upon any of the properties or assets of the
Company or any of its Subsidiaries or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time
or both) of, any Material Contract, or (iii) subject to the Stockholder Approval
and any Charter Amendment, conflict with or result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of
any court or governmental authority to which the Company or any of its
Subsidiaries is subject (including federal and state securities laws and
regulations and the rules and regulations, assuming the correctness of the
representations and warranties made by the Investors herein, of any
self-regulatory organization to which the Company or its securities are subject
including all applicable trading markets), or by which any property or asset of
the Company or any of its Subsidiaries is bound or affected, except in the case
of clauses (ii) and (iii) such as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. “Material Contract”
means any contract of the Company that was filed or required to be filed as an
exhibit to the SEC Reports pursuant to Item 601(b)(4) or Item 601(b)(10) of
Regulation S-K, other than any contract which has expired by its terms and does
not provide for the continuation of any material obligation on the part of the
Company following the date hereof.

 

SECTION 2.5 Filings, Consents and Approvals. The execution and delivery by the
Company of the Transaction Documents, and the performance by the Company of the
transactions contemplated hereby and thereby, do not and will not require the
Company to effectuate or obtain any registration with, consent or approval of,
or notice to any federal, state or other governmental authority or regulatory
body, other than periodic and other filings under the Securities Exchange Act of
1934, as amended (the “Exchange Act”), all required filings with the NASDAQ
Capital Market and, with respect to the transactions contemplated by Section
1.5, filings required under the Securities Act of 1933, as amended (the
“Securities Act”). The parties hereto agree and acknowledge that, in making the
representations and warranties in the foregoing sentence of this Section 2.5,
the Company is relying on the representations and warranties made by the
Investors in Article III.

 

SECTION 2.6 Issuance of Initial Securities. The Initial Securities have been
validly issued, and, upon payment therefor, will be fully paid and
non-assessable. The Note Conversion

 

5

 

 

Securities, when issued in accordance with the terms of the Rho Notes, will be
validly issued, fully paid and non-assessable. The Warrant Conversion
Securities, when issued in accordance with the terms of the Warrants, will be
validly issued, fully paid and non-assessable. The offering, issuance, sale and
delivery of (i) the Initial Securities as contemplated by this Agreement, (ii)
the Note Conversion Securities as contemplated by the Rho Note and (iii) the
Warrant Conversion Securities as contemplated by the Warrants, is (or will be),
as applicable, exempt from the registration and prospectus delivery requirements
of the Securities Act, are being (or will be) , as applicable, made in
compliance in all material respects with all applicable federal and state laws
and regulations concerning the offer, issuance and sale of securities, and are
not being (or will not be), as applicable, issued in violation of any preemptive
or other rights of any stockholder of the Company. The parties hereto agree and
acknowledge that, in making the representations and warranties in the foregoing
sentence of this Section 2.6, the Company is relying on the representations and
warranties made by the Investors in Article III.

 

SECTION 2.7 Capitalization. The aggregate number of shares and type of all
authorized, issued and outstanding classes of capital stock, options, warrants
and other securities of the Company (whether or not presently convertible into
or exercisable or exchangeable for shares of capital stock of the Company) as of
the Closing Date, is as set forth in the Capitalization Table delivered to the
Investors concurrently herewith (the “Capitalization Table”). All issued and
outstanding shares of capital stock are duly authorized, validly issued, fully
paid and non-assessable and have been issued in compliance in all material
respects with all applicable federal and state securities laws and none of such
outstanding securities were issued in violation of any preemptive rights or
similar rights to subscribe for or purchase any capital stock of the Company.
The Capitalization Table is true and accurate as of the Closing. Except as
disclosed in the Capitalization Table, as of the Closing, the Company did not
have outstanding any other options, warrants, securities convertible into Common
Stock, script rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or
exercisable or exchangeable for, or entered into any agreement giving any Person
any right to subscribe for or acquire, any shares of Common Stock, or securities
or rights convertible or exchangeable into shares of Common Stock. Except as set
forth in the Capitalization Table, and except for customary adjustments as a
result of stock dividends, stock splits, combinations of shares,
reorganizations, recapitalizations, reclassifications or other similar events,
there are no preemptive rights, anti-dilution or price adjustment provisions
contained in any security issued and outstanding by the Company (or in any
agreement providing rights to security holders) and the issuance and sale of the
Securities will not obligate the Company to issue shares of Common Stock or
other securities to any Person (other than the Investors) and will not result in
a right of any holder of securities to adjust the exercise, conversion, exchange
or reset price under such securities. Except as set forth in the Capitalization
Table, and except for the 2011 Agreement and the Company’s amended and restated
Voting Agreement, dated as of December 21, 2009, (A) there are no agreements or
arrangements under which the Company is obligated to register the sale of any of
its securities under the Securities Act, (B) there are no agreements or
arrangements pursuant to which any person has any co-sale rights, subscription
rights, rights of first refusal, rights of first offer, tag along rights, or
drag along rights, and (C) there are no agreements or arrangements relating to
the voting of securities of the Company, nor are there any other similar rights
relating to the, registration, transfer, sale or voting of the securities of the
Company. To the Company’s knowledge, except as disclosed in the SEC Reports and
any Schedules 13D or 13G filed with the

 

6

 

 

SEC pursuant to Rule 13d-1 of the Exchange Act by reporting persons or in
Schedule 2.7, as of the date hereof no person or group of related persons
beneficially owns (as determined pursuant to Rule 13d-3 under the Exchange Act),
or has the right to acquire, by agreement with or by obligation binding upon the
Company, beneficial ownership of in excess of 5% of the outstanding Common
Stock.

 

SECTION 2.8 SEC Reports; Disclosure Materials. The Company has filed all
reports, schedules, forms, statements and other documents required to be filed
by it under the Exchange Act, including pursuant to Section 13(a) or 15(d)
thereof, for the twelve months preceding the date hereof on a timely basis or
has received a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension and has filed all reports,
schedules, forms, statements and other documents required to be filed by it
under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two years preceding the date hereof. Such reports required to be filed
by the Company under the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, together with any materials filed or furnished by the Company
under the Exchange Act, whether or not any such reports were required being
collectively referred to herein as the “SEC Reports” and, together with this
Agreement and the Schedules to this Agreement, the “Disclosure Materials”. As of
their respective dates (or, if amended or superseded by a filing prior to the
Closing Date, then on the date of such filing), the SEC Reports filed by the
Company complied in all material respects with the requirements of the
Securities Act and the Exchange Act (as applicable) and the rules and
regulations of the Commission promulgated thereunder, and none of the SEC
Reports, when filed (or, if amended or superseded by a filing prior to the
Closing Date, then on the date of such filing) by the Company, contained any
untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. All
material agreements to which the Company is a party or to which the property or
assets of the Company are subject are included as part of or identified in the
SEC Reports, to the extent such agreements are required to be included or
identified pursuant to the rules and regulations of the Commission.

 

SECTION 2.9 Financial Statements. The financial statements of the Company
included in the SEC Reports comply (or, to the extent corrected by a subsequent
restatement that is filed with the Commission prior to the date hereof, as
corrected do comply) in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect
thereto as in effect at the time of filing. Such financial statements have been
prepared in accordance with U.S. generally accepted accounting principles, as
applied by the Company (“GAAP”), applied on a consistent basis during the
periods involved, except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all
material respects the financial position of the Company and its Subsidiaries as
of and for the dates thereof and the results of operations and cash flows for
the periods then ended, subject, in the case of unaudited statements, to normal,
year-end audit adjustments.

 

SECTION 2.10 Tax Matters. The Company and each of its Subsidiaries has (i)
prepared and filed all foreign, federal and state income and all other tax
returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) paid all taxes and other governmental

 

7

 

 

assessments and charges that are material in amount, shown or determined to be
due on such returns, reports and declarations, except those being contested in
good faith, with respect to which adequate reserves have been set aside on the
books of the Company or its Subsidiaries (as applicable) and (iii) set aside on
its books provisions reasonably adequate for the payment of all taxes for
periods subsequent to the periods to which such returns, reports or declarations
apply, except, in the case of clauses (i) and (ii) above, where the failure to
so pay or file any such tax, assessment, charge or return would not reasonably
be expected to have a Material Adverse Effect. There are no unpaid taxes in any
material amount claimed to be due by the taxing authority of any jurisdiction
and the officers of the Company know of no basis for any such claim.

 

SECTION 2.11 Material Changes; Undisclosed Events, Liabilities or Developments;
Solvency. Since the date of the latest financial statements included within the
SEC Reports, except as specifically disclosed in the SEC Reports, (i) there have
been no events, occurrences or developments that have had or would reasonably be
expected to have, either individually or in the aggregate, a Material Adverse
Effect, (ii) there has not been any material change or amendment to, or any
waiver of any material right by the Company under, any Material Contract, (iii)
all Material Contracts are in full force and effect except those that have
expired by their terms or as otherwise set forth in the SEC Reports and, to the
Company’s knowledge, no party to any Material Contract is in breach thereof in
any material respect, (iv) the Company’s business has been operated in the
ordinary course, (v) the Company has not incurred any material liabilities other
than (A) trade payables and accrued expenses incurred in the ordinary course of
business consistent with past practice and (B) liabilities not required to be
reflected in the Company’s financial statements pursuant to GAAP or required to
be disclosed in filings made with the Commission, (vi) the Company has not
altered its method of accounting or changed its auditors, except as disclosed in
its SEC Reports, (vii) the Company has not declared or made any dividend or
distribution of cash or other property to its stockholders, in their capacities
as such, or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock, and (viii) the Company has not issued any equity
securities to any officer, director or affiliate, except pursuant to existing
Company stock-based plans. The Company has not taken any steps to seek
protection pursuant to any bankruptcy law and, to the Company’s Knowledge, none
of its creditors intends to initiate involuntary bankruptcy proceedings and
there does not exist any fact which would reasonably lead a creditor to do so.
Based on the financial condition of the Company as of the Closing, after giving
effect to transactions contemplated hereby to occur at the Closing, the Company
reasonably expects to have sufficient cash on hand to pay all of its currently
foreseeable expenses for the next twelve months.

 

SECTION 2.12 Environmental Matters. To the Company’s knowledge, neither the
Company nor any of its Subsidiaries (i) is in violation of any statute, rule,
regulation, decision or order of any governmental agency or body or any court,
domestic or foreign, relating to the use, disposal or release of hazardous or
toxic substances or relating to the protection or restoration of the environment
or human exposure to hazardous or toxic substances (collectively, “Environmental
Laws”), (ii) owns or operates any real property contaminated with any substance
that is in violation of any Environmental Laws, (iii) is liable for any off-site
disposal or contamination pursuant to any Environmental Laws, or (iv) is subject
to any claim relating to any Environmental Laws; which, in the case of any of
the matters described in clauses (i) — (iv), has had or would reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect;
and, to the

 

8

 

 

Company’s knowledge, there is no pending or threatened investigation that might
lead to such a claim.

 

SECTION 2.13 Litigation. Except as set forth in Schedule 2.13, there is no
action, suit, inquiry, notice of violation, proceeding (including any partial
proceeding such as a deposition) or investigation pending or threatened in
writing against the Company or any of its properties or any officer, director or
employee of the Company acting in his or her capacity as an officer, director or
employee before or by any federal, state, county, local or foreign court,
arbitrator, governmental or administrative agency, regulatory authority, stock
market, stock exchange or trading facility (“Action”) (and in the case of any
inquiry or investigation, to the Company’s knowledge) before or by any court,
public board, government agency, self-regulatory organization or body pending
against or affecting the Company or any of its Subsidiaries, and no such Action
is currently threatened that could reasonably be expected to lead to the
commencement of an Action. The Commission has not issued any stop order or other
order suspending the effectiveness of any registration statement filed by the
Company under the Exchange Act or the Securities Act.

 

SECTION 2.14 Contracts. Schedule 2.14 lists the following contracts, agreements,
commitments or binding understanding, whether oral or written (collectively, the
“Contracts”), to which the Company or any of its Subsidiaries is a party or
subject or by which either the Company or any of its Subsidiaries is bound: (x)
each employment related Contract, (y) each Contract (A) with any Insider or (B)
between or among any insiders relating in any way to the Company; and (iii) each
Material Contract. “Insider” means (i) each of Quantum Industrial Partners LDC,
a Cayman Islands limited duration company, SFM Domestic Investments LLC, a
Delaware limited liability company, Maverick Fund USA, Ltd., a Texas limited
partnership, Maverick Fund, L.D.C., a Cayman Islands exempted limited duration
company, Maverick Fund II, Ltd., a Cayman Islands exempted company, Prentice
Consumer Partners, LP, a Delaware limited partnership and Rho Ventures VI, L.P.,
(ii) any existing officer or director of the Company, (iii) any member of the
immediate family of the persons described in clause (i) or (iv) any entity in
which any of the persons described in clause (i), (ii) or (iii) owns any
beneficial interest (other than less than one percent of the outstanding shares
of capital stock of any corporation whose stock is listed on a national
securities trading market). The term “person” means an individual, corporation,
partnership, limited liability company, trust, business trust, association,
joint stock company, joint venture, sole proprietorship, unincorporated
organization, governmental authority or any other form of entity not
specifically listed herein.

 

SECTION 2.15 Employment Matters. No material labor dispute exists or, to the
Company’s knowledge, is imminent with respect to any of the employees of the
Company or any of its Subsidiaries which would reasonably be expected to have a
Material Adverse Effect. The Company and each of its Subsidiaries is in
compliance with all U.S. federal, state, local and foreign laws and regulations
relating to employment and employment practices, terms and conditions of
employment and wages and hours, except where the failure to be in compliance
would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.

 

SECTION 2.16 Employee Relations. Neither the Company, nor any of its
Subsidiaries, is a party to any collective bargaining agreement. To the
Company’s knowledge, the Company’s and its Subsidiaries’ relations with their
respective employees are as disclosed in the SEC Reports.

 

9

 

 

Except as disclosed in the SEC Reports or as the Investors have otherwise been
made aware, no current executive officer of the Company has notified the Company
that such officer intends to leave the Company or otherwise terminate such
officer’s employment with the Company. To the Company’s knowledge, no executive
officer of the Company is in violation of any material term of any employment
Contract, confidentiality, disclosure or proprietary information agreement, non-
competition agreement, or any other contract or agreement or any restrictive
covenant, and the continued employment of each such executive officer does not
subject the Company to any liability with respect to any of the foregoing
matters.

 

SECTION 2.17 Labor Matters. The Company and each of its Subsidiaries is in
compliance in all material respects with all federal, state, local and foreign
laws and regulations respecting labor, employment and employment practices and
benefits, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.

 

SECTION 2.18 Minute Books. The minute books of the Company for the period from
2001 to present, all of which have been made available to the Investors, are
complete and correct. The minute books of the Company contain, in all material
respects, accurate records of all meetings held and actions taken by the board
of directors and committees of the board of directors of the Company during such
period, and no meeting of the board of directors or committees has been held for
which minutes are not contained in such minute books, other than meetings held
within the last sixty (60) days for which minutes have not yet been prepared
and/or approved by the board of directors or applicable committee.

 

SECTION 2.19 Affiliate Transactions. Except as disclosed in the SEC Reports, no
Insider has any agreement, contract, commitment or binding understanding,
whether oral or written, with the Company or any of its Subsidiaries (other than
the employment agreements filed with the Commission), any loan to or from the
Company or any of its Subsidiaries or any interest in any assets (whether real,
personal or mixed, tangible or intangible) used in or pertaining to the business
of the Company or any of its Subsidiaries (other than ownership of capital stock
of the Company). To the Company’s knowledge, except as set forth in the SEC
Reports, no director or officer has any direct or indirect interest in any
supplier of the Company or any of its Subsidiaries or in any Person from whom or
to whom the Company or any of its Subsidiaries leases any property, or in any
other Person with whom the Company or any of its Subsidiaries otherwise
transacts business of any nature, other than transactions entered into in the
ordinary course of business on the Company’s web site.

 

SECTION 2.20 Compliance. Neither the Company nor any of its Subsidiaries (i) is
in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by
the Company or its Subsidiaries under), nor has the Company or any of its
Subsidiaries received written notice of a claim that it is in default under or
that it is in violation of, any Material Contract (whether or not such default
or violation has been waived), (ii) is not in violation of any order of which
the Company or its Subsidiaries has been made aware in writing of any court,
arbitrator or governmental body having jurisdiction over the Company, its
Subsidiaries or their respective properties or assets, or (iii) is in violation
of, or in receipt of written notice that it is in violation of, any statute,
rule or regulation of any governmental

 

10

 

 

authority applicable to the Company or its Subsidiaries, except in each case as
would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.

 

SECTION 2.21 Regulatory Permits. The Company and each of its Subsidiaries
possesses or has applied for all certificates, authorizations and permits issued
by the appropriate federal, state, local or foreign regulatory authorities
necessary to conduct its business as currently conducted and as described in the
SEC Reports, except where the failure to possess such permits, individually or
in the aggregate, has not and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect (“Material
Permits”), and (i) neither the Company nor any of its Subsidiaries has received
any notice in writing of proceedings relating to the revocation or material
adverse modification of any such Material Permits and (ii) to the Company’s
knowledge, there do not exist any facts or circumstances that would give rise to
the revocation or material adverse modification of any Material Permits.

 

SECTION 2.22 Title to Assets. Neither the Company nor any of its Subsidiaries
owns any real property. Each of the Company and its Subsidiaries has good and
marketable title to all tangible personal property owned by it which is material
to the business of the Company, taken as a whole, free and clear of all liens
(other than liens under the Company’s senior credit facility) except such as do
not materially affect the value of such property and do not interfere with the
use made and proposed to be made of such property by the Company or its
Subsidiaries. Any real property and facilities held under lease by the Company
or its Subsidiaries are held by it under valid, subsisting and enforceable
leases with such exceptions as are not material and do not interfere with the
use made and proposed to be made of such property and buildings by the Company
or its Subsidiaries (as applicable).

 

SECTION 2.23 Insurance. The Company and each of its Subsidiaries is insured by
insurers of recognized financial responsibility against such losses and risks
and in such amounts as are prudent and customary in the businesses and locations
in which the Company or its Subsidiaries is engaged.

 

SECTION 2.24 Patents and Trademarks. The Company and each of its Subsidiaries
owns, possesses, licenses or has other rights to use all foreign and domestic
patents, patent applications, trade and service marks, trade and service mark
registrations, trade names, copyrights, inventions, trade secrets, technology,
Internet domain names, know-how and other intellectual property (collectively,
the “Intellectual Property”) necessary for the conduct of its business as now
conducted, as described in the SEC Reports (the “Company Intellectual
Property”). Except as set forth in the SEC Reports, (a) to the Company’s
knowledge, there are no rights of third parties to any such Company Intellectual
Property that is owned by the Company or its Subsidiaries; (b) to the Company’s
knowledge, there is no pending or threatened Action by others challenging the
Company’s or its Subsidiaries’ rights in or to any such Company Intellectual
Property that could reasonably be expected to have a Material Adverse Effect;
and (c) to the Company’s knowledge, there is no pending or threatened Action by
others that the Company or its Subsidiaries infringes or otherwise violates any
Intellectual Property of others that could reasonably be expected to have a
Material Adverse Effect.

 

11

 

 

SECTION 2.25 Internal Accounting Controls; Disclosure Controls. Except as has
not had or would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, the Company (i) has established and
maintained disclosure controls and procedures and internal control over
financial reporting (as such terms are defined in paragraphs (e) and (f),
respectively, of Rule 13a-15 under the Exchange Act) as required by Rule 13a-15
under the Exchange Act, and (ii) has disclosed, based on its most recent
evaluations, to its outside auditors and the audit committee of the board of
directors of the Company (A) all significant deficiencies and material
weaknesses in the design or operation of internal controls over financial
reporting (as defined in Rule 13a-15(f) of the Exchange Act) that are reasonably
likely to adversely affect the Company’s ability to record, process, summarize
and report financial data, and (B) any fraud known to the Company, whether or
not material, that involves management or other employees who have a significant
role in the Company’s internal controls over financial reporting.

 

SECTION 2.26 Sarbanes-Oxley. The Company is in compliance in all material
respects with all of the provisions of the Sarbanes-Oxley Act of 2002 which are
applicable to it, except where such noncompliance would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect.

 

SECTION 2.27 Foreign Corrupt Practices. Neither the Company, nor its
Subsidiaries, nor, to the Company’s knowledge, any director, officer, agent,
employee or other Person acting on behalf of the Company or its Subsidiaries
has, in the course of its actions for, or on behalf of, the Company or its
Subsidiaries (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii)
made any direct or indirect unlawful payment to any foreign or domestic
government official or employee or to any foreign or domestic political parties
or campaigns from corporate funds; (iii) violated or is in violation in any
material respect of any provision of the U.S. Foreign Corrupt Practices Act of
1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence
payment, kickback or other unlawful payment to any foreign or domestic
government official or employee.

 

SECTION 2.28 Off Balance Sheet Arrangements. There is no transaction,
arrangement, or other relationship between the Company or any of its
Subsidiaries and an unconsolidated or other off balance sheet entity that is
required to be disclosed by the Company in its SEC Filings and is not so
disclosed or that otherwise would reasonably be expected to have a Material
Adverse Effect.

 

SECTION 2.29 Indebtedness. Except as disclosed in the SEC Reports or as incurred
pursuant to transactions entered into in the ordinary course of business
including draws under the senior credit facility, since June 30, 2012, neither
the Company nor any of its Subsidiaries (i) has any outstanding indebtedness,
and (ii) is in violation of any term of or is in default under any contract,
agreement or instrument relating to any indebtedness, except where such
violations and defaults would not reasonably be expected to result, individually
or in the aggregate, in a Material Adverse Effect.

 

SECTION 2.30 Private Placement. Assuming the accuracy of the Purchasers’
representations and warranties set forth in Article III of this Agreement, no
registration under the Securities Act is required for the offer and sale of the
Initial Securities by the Company to the Purchasers under the Transaction
Documents.

 

12

 

 

SECTION 2.31 Registration Rights. Other than as set forth in the SEC Reports and
the Transaction Documents, no Person has any right to cause the Company to
effect the registration under the Securities Act of any securities of the
Company other than those securities which are currently registered on an
effective registration statement on file with the Commission.

 

SECTION 2.32 Listing and Maintenance Requirements. The Common Stock is
registered pursuant to Section 12(b) of the Exchange Act, and the Company has
taken no action designed to terminate the registration of the Common Stock under
the Exchange Act nor has the Company received any notification that the
Commission is contemplating terminating such registration. The Company has not,
in the twelve months preceding the date hereof, received written notice from any
trading market on which the Common Stock is listed or quoted to the effect that
the Company is not in compliance in all material respects with the listing and
maintenance requirements for continued trading of the Common Stock on the NASDAQ
Capital Market.

 

SECTION 2.33 Disclosure. The Company acknowledges and agrees that the Investors
have not made any representations or warranties with respect to the transactions
contemplated hereby other than those set forth in the Transaction Documents.

 

SECTION 2.34 Brokers. Except for the payment of the Origination Fee, neither the
Company, nor any of its officers, directors or employees, has employed any
broker or finder, or incurred any liability for any brokerage fees, commissions,
finder’s or other similar fees or expenses in connection with the transactions
contemplated hereby.

 

ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE INVESTORS

 

Each Investor hereby represents and warrants, severally as to itself and not
jointly, to the Company as follows:

 

SECTION 3.1 Organization; Authority. Such Investor is a an entity duly formed,
validly existing and in good standing under the laws of the jurisdiction set
forth next to its name on Schedule 1, with the requisite power and authority to
enter into and to consummate the transactions contemplated by this Agreement and
the other Transaction Documents to which it is a party and otherwise to carry
out its obligations hereunder and thereunder. The execution, delivery and
performance by such Investor of the transactions contemplated by this Agreement
and the other Transaction Documents to which it is a party have been duly
authorized by all necessary action on the part of such Investor, and no further
action is required by such Investor (or its respective managing member or
general partner, if applicable) in connection therewith. This Agreement and the
other Transaction Documents to which such Investor is a party have been duly
executed by such Investor, and when delivered by such Investor in accordance
with the terms hereof and thereof, each will constitute the valid and legally
binding obligation of such Investor, enforceable against it in accordance with
its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally the enforcement of, creditors’ rights and
remedies or by other equitable principles of general application.

 

13

 

 

SECTION 3.2 No Conflicts. The execution, delivery and performance by such
Investor of this Agreement and the other Transaction Documents to which it is a
party and the consummation by such Investor of the transactions contemplated
hereby and thereby will not (i) result in a violation of the formation documents
of such Investor, (ii) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to
others any rights of termination, amendment, acceleration or cancellation of,
any agreement, indenture or instrument to which such Investor is a party, or
(iii) result in a violation of any law, rule, regulation, order, judgment or
decree (including federal and state securities laws) applicable to such
Investor, except in the case of clauses (ii) and (iii) above, for such
conflicts, defaults, rights or violations which would not, individually or in
the aggregate, reasonably be expected to have a material adverse effect on the
ability of such Investor to perform its obligations hereunder.

 

SECTION 3.3 Filings, Consents and Approvals. Such Investor is not required to
obtain any consent, waiver, authorization or order of, give any notice to, or
make any filing or registration with, any court or other federal, state, local
or other governmental authority or other person in connection with the
execution, delivery and performance by such Investor of the Transaction
Documents.

 

SECTION 3.4 Investment Representations. Such Investor acknowledges that the
offer and sale of the Securities to such Investor have not been registered under
the Securities Act, or the securities laws of any state or regulatory body, are
being offered and sold in reliance upon exemptions from the registration
requirements of the Securities Act and such laws and may not be transferred or
resold without registration under such laws unless an exemption is available.

 

(a)          Such Investor is acquiring the Securities for investment, and not
with a view to the resale or distribution thereof, and is acquiring the
Securities for its own account.

 

(b)          Such Investor is an “accredited investor” (as that term is defined
in Rule 501 of Regulation D promulgated under the Securities Act). Such Investor
acknowledges that it has had the opportunity to review the Disclosure Materials
and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company
concerning the terms and conditions of the offering of the Securities and the
merits and risks of investing in the Securities; (ii) access to information
about the Company and its financial condition, results of operations, business,
properties, management and prospects sufficient to enable it to evaluate its
investment; and (iii) the opportunity to obtain such additional information that
the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the
investment. Neither such inquiries nor any other investigation conducted by or
on behalf of such Investor or its representatives or counsel shall modify, amend
or affect such Investor’s right to rely on the truth, accuracy and completeness
of the Disclosure Materials and the Company’s representations and warranties
contained in the Transaction Documents. Such Investor has sought such
accounting, legal and tax advice as it has considered necessary to make an
informed decision with respect to its acquisition of the Securities. Such
Investor acknowledges and agrees that the Company has not made any
representations or warranties with respect to the transactions contemplated
hereby other than those set forth in the Transaction Documents.

 

14

 

 

(c)          Such Investor, either alone or together with its representatives,
has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the
prospective investment in the Securities, and has so evaluated the merits and
risks of such investment. Such Investor is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a
complete loss of such investment.

 

(d)          Neither such Investor, nor any of its principal owners, partners,
members, directors or officers is included on the Office of Foreign Assets
Control list of foreign nations, organizations and individuals subject to
economic and trade sanctions, based on U.S. foreign policy and national security
goals, or a person named on the list of known or suspected terrorists, terrorist
organizations or other sanctioned persons issued by the U.S. Treasury
Department’s Office of Foreign Assets and Control.

 

SECTION 3.5 Reliance on Exemptions. Such Investor understands that the
Securities being offered and sold to it in reliance on specific exemptions from
the registration requirements of United States federal and state securities laws
and that the Company is relying in part upon the truth and accuracy of, and such
Investor’s compliance with, the representations, warranties, agreements,
acknowledgements and understandings of such Investor set forth herein in order
to determine the availability of such exemptions and the eligibility of such
Investor to acquire the Securities.

 

SECTION 3.6 No Governmental Review. Such Investor understands that no United
States federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Securities or the
fairness or suitability of the investment in the Securities nor have such
authorities passed upon or endorsed the merits of the offering of the
Securities.

 

SECTION 3.7 Office. Such Investor’s office in which its investment decision with
respect to the Securities was made is located at the address set forth opposite
its name on Schedule 1.

 

SECTION 3.8 Brokers. Neither the Investors, nor any of their officers, directors
or employees, has employed any broker or finder, or incurred any liability for
any brokerage fees, commissions, finder’s or other similar fees or expenses in
connection with the transactions contemplated hereby.

 

SECTION 3.9 Disclosure. The Investors acknowledge and agree that the Company has
not made any representations or warranties with respect to the transactions
contemplated hereby other than those set forth in the Transaction Documents.

 

ARTICLE IV
SURVIVAL; INDEMNIFICATION

 

SECTION 4.1 Survival. The representations and warranties contained in Articles
II and III hereof shall survive the Closing and the delivery of the Notes.

 

SECTION 4.2 Indemnification.

 

15

 

 

(a)          Indemnification of the Investors. The Company will indemnify and
hold each Investor and its respective directors, officers, stockholders,
members, partners, employees and agents (and any other persons with a
functionally equivalent role of a person holding such titles notwithstanding a
lack of such title or any other title), each person who controls such Investor
(within the meaning of Section 15 of the Securities Act and Section 20 of the
Exchange Act), and the directors, officers, stockholders, agents, members,
partners or employees (and any other persons with a functionally equivalent role
of a person holding such titles notwithstanding a lack of such title or any
other title) of such controlling person (each, an “Investor Party”) harmless
from any and all losses, liabilities, obligations, claims, contingencies,
damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys’ fees and costs of
investigation that such Investor Party may suffer or incur arising from or
relating to any of the representations, warranties, covenants or agreements made
by the Company in this Agreement or in the other Transaction Documents. The
Company will not be liable to any Investor Party under this Agreement to the
extent, but only to the extent that a loss, claim, damage or liability is
attributable to such Investor Party’s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this
Agreement or in the other Transaction Documents.

 

(b)          Indemnification of the Company. Each Investor will severally and
not jointly indemnify and hold the Company and its directors, officers,
stockholders, members, partners, employees and agents (and any other persons
with a functionally equivalent role of a person holding such titles
notwithstanding a lack of such title or any other title), each person who
controls the Company (within the meaning of Section 15 of the Securities Act and
Section 20 of the Exchange Act), and the directors, officers, stockholders,
agents, members, partners or employees (and any other persons with a
functionally equivalent role of a person holding such titles notwithstanding a
lack of such title or any other title) of such controlling person (each, a
“Company Party”) harmless from any and all losses, liabilities, obligations,
claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees and
costs of investigation that the Company Party may suffer or incur arising from
or relating to any of the representations, warranties, covenants or agreements
made by such Investor in this Agreement or in the other Transaction Documents.

 

SECTION 4.3 Conduct of Indemnification Proceedings. Promptly after receipt by
any party (the “Indemnified Person”) of notice of any demand, claim or
circumstances which would or might give rise to a claim or the commencement of
any action, proceeding or investigation in respect of which indemnity may be
sought pursuant to Section 4.2(a) or (b), such Indemnified Person shall promptly
notify the Company and the other Investor or if the Indemnified Person is the
Company, shall notify the Investors, as applicable (the party against whom
indemnity may be sought hereinafter referred to as the “Indemnifying Person”),
in writing and the Indemnifying Person shall assume the defense thereof,
including the employment of counsel reasonably satisfactory to such Indemnified
Person, and shall assume the payment of all fees and expenses; provided,
however, that the failure of any Indemnified Person to so notify the
Indemnifying Person shall not relieve the Indemnifying Person of its obligations
hereunder except to the extent that the Indemnifying Person is actually and
materially and adversely prejudiced by such failure to notify. In any such
proceeding, any Indemnified Person shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of
such Indemnified Person unless: (i)

 

16

 

 

the Indemnifying Person and the Indemnified Person shall have mutually agreed to
the retention of such counsel; (ii) the Indemnifying Person shall have failed
promptly to assume the defense of such proceeding and to employ counsel
reasonably satisfactory to the Indemnified Person in such proceeding; or (iii)
in the reasonable judgment of counsel to the Indemnified Person, there exists or
shall exist a conflict of interest that would make it inappropriate for the same
counsel to represent both the Indemnified Person and the Indemnifying Person.
The Indemnifying Person shall not be liable for any settlement of any proceeding
effected without its written consent, which consent shall not be unreasonably
withheld, delayed or conditioned unless the Indemnifying Person fails to defend
any proceeding or fails to promptly respond to a settlement offer. Without the
prior written consent of the Indemnified Person, which consent shall not be
unreasonably withheld, delayed or conditioned, the Indemnifying Person shall not
effect any settlement of any pending or threatened proceeding in respect of
which any Indemnified Person is or could have been a party and indemnity could
have been sought hereunder by such Indemnified Party, unless such settlement
includes an unconditional release of such Indemnified Person from all liability
arising out of such proceeding.

 

ARTICLE V
CONDITIONS PRECEDENT TO CLOSING

 

SECTION 5.1 Conditions Precedent to the Obligations of the Investors at Closing.
The obligation of each Investor to purchase the Initial Securities opposite its
respective name on Schedule 1 at the Closing is subject to the fulfillment, on
or prior to the date hereof (the “Closing Date”), of each of the following
conditions, any of which may be waived by an Investor as with respect to its
obligations:

 

(a)          Representations and Warranties. The representations and warranties
of the Company contained herein shall be true and correct in all material
respects as of the Closing Date, except for such representations and warranties
that speak as of a specific date, in which case such representations and
warranties shall have been true and correct in all material respects as of such
date.

 

(b)          Performance. The Company shall have performed, satisfied and
complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied
with by it at or prior to Closing.

 

(c)          No Injunction. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction that
prohibits the consummation of any of the transactions contemplated in the
Transaction Documents.

 

(d)          Consents. The Company shall have obtained in a timely fashion any
and all consents, permits, approvals, registrations and waivers necessary for
consummation of the purchase and sale of the Initial Securities at the Closing,
all of which shall be and remain so long as necessary in full force and effect.

 

(e)          No Suspensions of Trading in Common Stock; Listing. The Common
Stock (i) shall be designated for quotation or listed on the NASDAQ Capital
Market and (ii) shall not have been suspended, as of the Closing Date, by the
Commission or the NASDAQ Capital Market

 

17

 

 

from trading on the NASDAQ Capital Market nor shall suspension by the Commission
or the NASDAQ Capital Market have been threatened, as of the Closing Date,
either (A) in writing by the Commission or the NASDAQ Capital Market or (B) by
falling below the minimum listing maintenance requirements of the NASDAQ Capital
Market.

 

(f)          Company Deliverables. The Company shall have issued, delivered or
caused to have been delivered to the Investors each of the following:

 

(i)          each of the Transaction Documents, duly executed by the Company;

 

(ii)          a legal opinion of counsel to the Company, dated as of the Closing
Date, executed by such counsel and addressed to the Investors;

 

(iii)          a certificate of the Secretary of the Company (the “Secretary’s
Certificate”), dated as of the Closing Date, (a) certifying the resolutions
adopted by the Board of Directors of the Company or a duly authorized committee
thereof approving the transactions contemplated by this Agreement and the other
Transaction Documents and the issuance of the Securities, (b) certifying the
current versions of the certificate of incorporation, as amended, and by-laws,
as amended of the Company and (c) certifying as to the signatures and authority
of persons signing the Transaction Documents and related documents on behalf of
the Company;

 

(iv)          a certificate evidencing the formation and good standing of the
Company in the State of Delaware issued by the Secretary of State (or comparable
office) of such jurisdiction, as of a date within five (5) business days of the
Closing Date;

 

(v)          a certificate evidencing the Company’s qualification as a foreign
corporation in good standing issued by the States of New York and Ohio, as of a
date within five (5) business days of the Closing Date; and

 

(g)          Compliance Certificate. The Company shall have delivered to the
Investors a certificate, dated as of the Closing Date and signed by its Chief
Executive Officer or its Chief Financial Officer, certifying to the fulfillment
of the conditions specified in Sections 5.1(a) and 5.1(b).

 

SECTION 5.2 Conditions Precedent to the Obligations of the Company at Closing.
The Company’s obligation to sell and issue the Initial Securities at the Closing
is subject to the fulfillment to the satisfaction of the Company on or prior to
the Closing Date of the following conditions, any of which may be waived by the
Company:

 

(a)          Representations and Warranties. The representations and warranties
of the Investors contained herein shall be true and correct in all material
respects as of the Closing Date, except for such representations and warranties
that speak as of a specific date, in which case such representations and
warranties shall have been true and correct in all material respects as of such
date.

 

18

 

 

(b)          Performance. The Investors shall have performed, satisfied or
complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied
with by the Investors at or prior to Closing.

 

(c)          No Injunction. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction that
prohibits the consummation of any of the transactions contemplated in the
Transaction Documents.

 

(d)          Consents. The Company shall have obtained in a timely fashion any
and all consents, permits, approvals, registrations and waivers necessary for
consummation of the purchase and sale of the Initial Securities at the Closing,
all of which shall be and remain so long as necessary in full force and effect.

 

(e)          Investor Deliverables. Each Investor shall have delivered or caused
to have been delivered to the Company the following:

 

(i)          each of the Transaction Documents to which such Investor is a
party, duly executed by such Investor; and

 

(ii)          the Purchase Price in United States dollars and in immediately
available funds, by wire transfer to an account designated in writing to the
Investors by the Company for such purpose.

 

ARTICLE VI
MISCELLANEOUS

 

SECTION 6.1 Fees and Expenses.

 

(a)          At the Closing, the Company shall reimburse the Investors for their
reasonable legal fees and expenses incurred in connection with the transactions
contemplated by this Agreement; provided, however, that (i) in no event shall
the Investors be entitled to receive in the aggregate an amount from the Company
pursuant to this Section 5.1(a) in excess of $40,000 and (ii) each Investor
shall provide the Company with reasonably detailed invoices for such fees and
expenses. Other than as provided with respect to legal fees and expenses
described in the immediately preceding sentence, each Investor shall pay the
fees and expenses of their respective advisers, counsel, accountants and other
experts, if any, and all other expenses incurred by such party in connection
with the negotiation, preparation, execution, delivery and performance of this
Agreement and the other Transaction Documents.

 

(b)          At the Closing, the Company shall pay to Prentice by wire transfer
of immediately available funds an origination fee of Thirty Thousand Dollars
($30,000) (the “Origination Fee”).

 

SECTION 6.2 Publicity. Except as may be required by applicable law or the rules
of any securities exchange or market on which securities of the Company are
traded, no party hereto shall issue a press release or public announcement or
otherwise make any disclosure concerning this

 

19

 

 

Agreement and the transactions contemplated hereby, without prior approval of
the others; provided, however, that nothing in this Agreement shall restrict the
Company or any Investor from disclosing such information (a) that is already
publicly available, (b) to the extent required or appropriate in response to any
summons or subpoena or to comply with applicable law, regulations or the rules
of any national securities exchange or quotation system (provided that the
disclosing party will use commercially reasonable efforts to notify the other
parties in advance of such disclosure under this clause (b) so as to permit the
non-disclosing parties, in the case of a summons or subpoena, seek a protective
order or otherwise contest such disclosure, and the disclosing party will use
commercially reasonable efforts to cooperate, at the expense of the
non-disclosing parties, in pursuing any such protective order) or (c) in
connection with any litigation involving disputes as to the parties’ respective
rights and obligations hereunder.

 

SECTION 6.3 Entire Agreement. This Agreement and the other Transaction Documents
constitute the entire Agreement between the parties hereto with respect to the
subject matter hereof and supersede all previous negotiations, commitments and
writings with respect to such subject matter.

 

SECTION 6.4 Assignments; Parties in Interest. Neither this Agreement nor any of
the rights, interests or obligations hereunder may be assigned by any of the
parties hereto (whether by operation of law or otherwise) without the prior
written consent of the other parties. This Agreement shall be binding upon and
inure solely to the benefit of each party hereto, and nothing herein, express or
implied, is intended to or shall confer upon any person not a party hereto any
right, benefit or remedy of any nature whatsoever under or by reason hereof,
except as otherwise provided herein.

 

SECTION 6.5 Amendments. This Agreement may not be amended or modified except by
an instrument in writing signed by, or on behalf of, the parties against whom
such amendment or modification is sought to be enforced.

 

SECTION 6.6 Descriptive Headings. The descriptive headings of this Agreement are
inserted for convenience of reference only and do not constitute a part of and
shall not be utilized in interpreting this Agreement.

 

SECTION 6.7 Notices and Addresses. Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in writing
and shall be deemed given and effective on the earliest of (a) the date of
transmission, if such notice or communication is delivered via facsimile
(provided the sender receives a machine-generated confirmation of successful
transmission) at the facsimile number specified in this Section 6.7 prior to
5:00 p.m., Eastern Standard Time, on a business day, (b) the next business day
after the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number specified in this Section 6.7 on a day that is
not a Trading Day or later than 5:00 p.m., Eastern Standard Time, on any
business day, (c) the business day following the date of mailing, if sent by
U.S. nationally recognized overnight courier service with next day delivery
specified, or (d) upon actual receipt by the party to whom such notice is
required to be given. The address for such notices and communications shall be
as follows:

 

20

 

 

To Company:Bluefly, Inc.

42 West 39th Street, 9th Floor

New York, New York 10018

Fax:(212) 840-1903

Attn:General Counsel

 

With a copy to:

 

Dechert LLP

30 Rockefeller Plaza

New York, NY 10112-2200

Fax:(212) 698-3599

Attn:Richard A. Goldberg, Esq.

 

To the Investors:To the address set forth on Schedule 1;

 

With a copy to:

 

Goodwin Procter LLP

The New York Times Building

620 Eighth Avenue

New York, NY 10112-2200

Fax:(212) 355-3333

Attn:Stephen M. Davis, Esq.

 

SECTION 6.8 Severability. In the event that any provision of this Agreement
becomes or is declared by a court of competent jurisdiction to be illegal, void
or unenforceable, the remainder of this Agreement will continue in full force
and effect and the application of such provision to other persons or
circumstances will be interpreted so as reasonably to effect the intent of the
parties hereto. The parties further agree to replace such void or unenforceable
provision of this Agreement with a valid and enforceable provision that will
achieve, to the extent possible, the economic, business and other purposes of
such void or unenforceable provision.

 

SECTION 6.9 Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York, without regard to the principles of conflicts of law thereof. Each party
agrees that all proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other
Transaction Documents (whether brought against a party hereto or its respective
affiliates, employees or agents) shall be commenced exclusively in the
applicable courts located in the State of New York. Each party hereto hereby
irrevocably submits to the exclusive jurisdiction of the applicable courts
located in the County of New York, State of New York for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein (including with respect to the enforcement of any of
the Transaction Documents), and hereby irrevocably waives, and agrees not to
assert in any proceeding, any claim that it is not personally subject to the
jurisdiction of any such courts located in the County of New York, State

 

21

 

 

of New York, or that such proceeding has been commenced in an improper or
inconvenient forum. Each party hereto hereby irrevocably waives personal service
of process and consents to process being served in any such proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner
permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY
LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY.

 

SECTION 6.10 Execution; Counterparts. This Agreement may be executed in two or
more counterparts, all of which when taken together shall be considered one and
the same agreement and shall become effective when counterparts have been signed
by each party and delivered to the other party, it being understood that both
parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission, or by e-mail delivery of a “.pdf’ format
data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile signature page were an original thereof.

 

[Signature Page Follows]

 

22

 

 

IN WITNESS WHEREOF, this Agreement has been duly executed on the date first set
forth above.

 

  BLUEFLY, INC.       By: / s / Joseph Park     Name: Joseph Park     Title: CEO
          RHO VENTURES VI, L.P.       By: RMV VI, L.L.C., its General Partner  
    By: Rho Capital Partners LLC, its Managing Member           By: / s /
Jeffrey Martin     Name: Jeffrey Martin     Title: Attorney-in-fact          
PRENTICE CONSUMER PARTNERS, LP       By: Prentice Consumer Partners GP, LLC, its
General Partner           By: / s / Mario Ciampi     Name: Mario Ciampi    
Title: Managing Partner

 

23

 

  

SCHEDULE 1

 

investors

 

Name and Address of Investor Aggregate Principal
Amount of Note Shares of Common Stock Issuable upon Exercise of Warrants
Aggregate Purchase Price

Prentice Consumer Partners, LP
623 Fifth Avenue, 32nd Floor

New York, NY 10022

 

$1,500,000 476,190 $1,500,000

Rho Ventures VI, L.P.

152 West 57th Street, 23rd Floor

New York, NY 10022

 

$1,500,000 476,190 $1,500,000 TOTAL $3,000,000 952,380 $3,000,000

 

 

 

 

Disclosure Schedules

 

These Disclosure Schedules are being furnished to the Investors in connection
with the execution and delivery of the Note and Warrant Purchase Agreement,
dated August 13, 2012, by and among Bluefly, Inc., a Delaware corporation (the
“Company”) and the Investors (the “Agreement”). All capitalized terms used in
these Disclosure Schedules have the meanings used in the Agreement, unless
otherwise indicated.

 

No reference to or disclosure of any item or other matter in these Disclosure
Schedules shall be construed as an admission to any third party or indication to
any third party that such item or other matter is material or would have a
material adverse effect or that such item or other matter is required to be
referred to or disclosed in these Disclosure Schedules. No disclosure in these
Disclosure Schedules relating to any possible breach, violation or conflict of
any contract or legal requirement shall be construed as an admission or
indication that any such breach, violation or conflict exists or has actually
occurred. Matters reflected in these Disclosure Schedules are not necessarily
limited to matters required by the Agreement to be reflected in these Disclosure
Schedules.

 

 

 

 

SCHEDULE 2.7

 

CAPITALIZATION

 

None.

 

 

 

 

SCHEDULE 2.13

 

LITIGATION

 

The Company is currently party to the following Actions:

 

1.Bluefly, Inc. v. Love from Australia, LLC and Stuart Rush, Supreme Court of
the State of New York, County of New York.    

2.Center for Environmental Health v. Two’s Company, Inc., et al, Superior Court
of the State of California, County of Alameda.    

3.Select Retrieval, LLC v. Amerimakr Direct LLC et al, U.S. District Court for
the District of Delaware.    

In addition, the Company from time to time receives communications regarding
threatened Actions alleging that the Company’s e-commerce and related activities
infringement upon various patents that purport to cover methods and practices
that are commonly used by most participants in the ecommerce industry. While one
or more of these communications could reasonably be expected to lead to an
Action regarding such infringement allegations, the Company does not believe
that any such Action could reasonably be expected to have a Material Adverse
Effect.

 

 

 

 

SCHEDULE 2.14

 

CONTRACTS

 

Investment Agreement, dated November 13, 2000, by and among the Company, Bluefly
Merger Sub, Inc., Quantum Industrial Partners LDC and SFM Domestic Investments
LLC.

 

Common Stock and Warrant Purchase Agreement, dated May 24, 2002, by and between
the Company and the investors listed on Schedule 1 thereto.

 

Note and Warrant Purchase Agreement, dated January 28, 2003, by and between the
Company and the investors listed on Schedule 1 thereto.

 

Common Stock and Warrant Purchase Agreement dated January 9, 2004 by and among
the Company and the Investors listed on Schedule 1 thereto.

 

Master Service Agreement, dated as of February 28, 2005, by and between the
Company and Level 3 Communications, LLC.

 

Customer Order Addendum, dated as of February 28, 2005, by and between the
Company and Level 3 Communications, LLC.

 

Preferred Stock and Warrant Purchase Agreement, dated as of June 24, 2005, by
and among the Company and the Investors listed on the signature page thereto.

 

Amended and Restated Credit Agreement, dated as of June 17, 2011, by and between
the Company and Wells Fargo Bank, National Association

 

Amended and Restated Security Agreement, dated as of June 17, 2011, by and
between the Company and Wells Fargo Bank, National Association

 

Stock Purchase Agreement, dated as of June 5, 2006, by and among Bluefly, Inc.,
Quantum Industrial Partners LDC, SFM Domestic Investments, LLC and the investors
listed on the signature pages attached thereto.

 

Fee Letter, dated June 5, 2006, by and among Bluefly, Inc., Quantum Industrial
Partners LDC and SFM Domestic Investments, LLC.

 

Master License Agreement, dated as of September 28, 2006, by and between the
Company and Art Technology Group, Inc.

 

Fulfillment Services Agreement, dated as of April 11, 2007, by and between the
Company and Fulfillment Technologies, LLC.

 

Service Agreement, dated as of May 9, 2007, by and between the Company and
VIPdesk Connect, Inc.

 

 

 

 

Letter Agreement, dated as of December 21, 2007, by and between the Company and
Fulfillment Technologies, LLC.

 

Third Amended and Restated Employment Agreement, dated as of May 3, 2011, by and
between the Company and Kara B. Jenny.

 

Standby Commitment Agreement, dated as of March 26, 2008, by Quantum Industrial
Partners LDC, SFM Domestic Investments LLC and private funds associated with
Maverick Capital, Ltd. in favor of the Company.

 

Amended and Restated Warrant No. 1, dated April 8, 2008 and effective as of
March 26, 2008, issued to Quantum Industrial Partners LDC.

 

Amended and Restated Warrant No. 2 dated April 8, 2008 and effective as of March
26, 2008, issued to SFM Domestic Investments LLC.

 

Amended and Restated Warrant No. 3 dated April 8, 2008 and effective as of March
26, 2008, issued to Maverick Fund USA, Ltd.

 

Amended and Restated Warrant No. 4 dated April 8, 2008 and effective as of March
26, 2008, issued to Maverick Fund LDC.

 

Amended and Restated Warrant No. 5 dated April 8, 2008 and effective as of March
26, 2008, issued to Maverick Fund II, Ltd.

 

Letter Agreement, dated as of November 19, 2008, by and between the Company and
Fulfillment Technologies, LLC

 

Securities Purchase Agreement, dated as of December 21, 2009, between Bluefly,
Inc. and Rho Ventures VI, LP

 

Amended and Restated Voting Agreement, dated as of December 21, 2009, among
Bluefly, Inc., Quantum Industrial Partners LDC, SFM Domestic Investments, LLC,
Maverick Fund USA, Ltd., Maverick Fund, L.D.C., Maverick Fund II, Ltd., Prentice
Capital Partners, LP, Prentice Capital Partners QP, LP, Prentice Capital
Offshore, Ltd., S.A.C. Capital Associates, LLC, GPC XLIII, LLC, PEC I, LLC and
Rho Ventures VI, LP

 

Lease Agreement by and between the Company and 42-52 West 39 Street LLC, dated
March 17, 2010

 

Operating Agreement of Eyefly LLC, dated as of January 4, 2011

 

Management Services Agreement, dated as of January 4, 2011, by and between
Eyefly LLC and the Company

 

 

 

 

Management Services Agreement, dated as of January 4, 2011, by and between
Eyefly LLC and Tworoger Associates, Ltd.

 

Second Amended and Restated Employment Agreement, dated as of May 3, 2011, by
and between the Company and Cristyn Girolami

 

Third Amended and Restated Employment Agreement, dated as of May 3, 2011, by and
between the Company and Martha Ottavio

 

Second Amended and Restated Employment Agreement, dated as of May 3, 2011, by
and between the Company and Martin Keane

 

Amended and Restated Employment Agreement, dated as of February 2, 2012, by and
between the Company and Joseph Park

 

Separation Agreement, dated February 2, 2012, by and between Bluefly, Inc. and
Melissa Payner-Gregor

 

Securities Purchase Agreement dated as of September 7, 2011, by and among the
Company and each of the Purchasers named on Schedule 1 thereto

 

Amended and Restated Registration Rights Agreement dated as of September 7,
2011, by and among the Company, Quantum Industrial Partners LDC, SFM Domestic
Investments, LLC, Maverick Fund USA, Ltd., Maverick Fund, L.D.C., Maverick Fund
II, Ltd., Prentice Consumer Partners, LP and Rho Ventures VI, L.P.

 

The Company has entered into standard form agreements with directors, officers
and other employees related to grants under the Company’s stock incentive plans
as well as (in the case of officers and other employees) matters related to
confidentiality, non-compete, non-solicitation and assignment of inventions.

 

 

 

 

EXHIBIT A

 

FORM OF PRENTICE NOTES

 

[attached]

 

 

 

 

EXHIBIT B

 

FORM OF RHO NOTES

 

[attached]

 

 

 

 

EXHIBIT C

 

FORM OF PRENTICE & RHO WARRANT

 

[attached]